Wang Zhao V, Schraw Todd D, Kim Ja-Young, Khan Tayeba, Rajala Michael W, Follenzi Antonia, Scherer Philipp E
Department of Cell Biology, Albert Einstein College of Medicine, 1300 Morris Park Avenue, Bronx, NY 10461, USA.
Mol Cell Biol. 2007 May;27(10):3716-31. doi: 10.1128/MCB.00931-06. Epub 2007 Mar 12.
Adiponectin is a secretory protein abundantly secreted from adipocytes. It assembles into a number of different higher-order complexes. Adipocytes maintain tight control over circulating plasma levels, suggesting the existence of a complex, highly regulated biosynthetic pathway. However, the critical mediators of adiponectin maturation within the secretory pathway have not been elucidated. Previously, we found that a significant portion of de novo-synthesized adiponectin is not secreted and retained in adipocytes. Here, we show that there is an abundant pool of properly folded adiponectin in the secretory pathway that is retained through thiol-mediated retention, as judged by the release of adiponectin in response to treatment of adipocytes with reducing agents. Adiponectin is covalently bound to the ER chaperone ERp44. An adiponectin mutant lacking cysteine 39 fails to stably interact with ERp44, demonstrating that this residue is the primary site mediating the covalent interaction. Another ER chaperone, Ero1-Lalpha, plays a critical role in the release of adiponectin from ERp44. Levels of both of these proteins are highly regulated in adipocytes and are influenced by the metabolic state of the cell. While less critical for the secretion of trimers, these chaperones play a major role in the assembly of higher-order adiponectin complexes. Our data highlight the importance of posttranslational events controlling adiponectin levels and the release of adiponectin from adipocytes. One mechanism for increasing circulating levels of specific adiponectin complexes by peroxisome proliferator-activated receptor gamma agonists may be selective upregulation of rate-limiting chaperones.
脂联素是一种由脂肪细胞大量分泌的分泌性蛋白质。它组装成多种不同的高阶复合物。脂肪细胞严格控制循环血浆水平,这表明存在一个复杂的、高度调控的生物合成途径。然而,分泌途径中脂联素成熟的关键介质尚未阐明。此前,我们发现新合成的脂联素中有很大一部分没有分泌,而是保留在脂肪细胞中。在这里,我们表明分泌途径中存在大量正确折叠的脂联素,通过巯基介导的保留作用被保留,这是通过用还原剂处理脂肪细胞后脂联素的释放来判断的。脂联素与内质网伴侣蛋白ERp44共价结合。缺乏半胱氨酸39的脂联素突变体无法与ERp44稳定相互作用,表明该残基是介导共价相互作用的主要位点。另一种内质网伴侣蛋白Ero1-Lalpha在脂联素从ERp44的释放中起关键作用。这两种蛋白质在脂肪细胞中的水平都受到高度调控,并受细胞代谢状态的影响。虽然这些伴侣蛋白对三聚体的分泌不太关键,但它们在高阶脂联素复合物的组装中起主要作用。我们的数据突出了控制脂联素水平的翻译后事件以及脂联素从脂肪细胞释放的重要性。过氧化物酶体增殖物激活受体γ激动剂增加特定脂联素复合物循环水平的一种机制可能是限速伴侣蛋白的选择性上调。